In the US, Rituximab (rituximab systemic) is a member of the following drug classes: antirheumatics, CD20 monoclonal antibodies and is used to treat Bullous Pemphigoid, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Evan's Syndrome, Focal Segmental Glomerulosclerosis, Follicular Lymphoma, Granulomatosis with Polyangiitis, Idiopathic Thrombocytopenic Purpura, Mantle Cell Lymphoma, Microscopic Polyangiitis, Non-Hodgkin's Lymphoma, Pemphigus Vulgaris and Rheumatoid Arthritis.

US matches:

• Rituximab
• Rituximab and hyaluronidase human, recombinant
• Rituximab-abbs
• Rituximab-arrx
• Rituximab-pvvr

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC02

CAS registry number (Chemical Abstracts Service)

0174722-31-7

Chemical Formula

C6416-H9874-N1688-O1987-S44

Molecular Weight

143860

Therapeutic Categories

Immunosuppressant

Antineoplastic agent

Microtubule inhibitor

Biological response modifier, BRM

Anti-CD20 monoclonal antibody

Chemical Name

Immunoglobulin G 1 (human-mouse monoclonal IDEC-C2B8 gama 1-chain anti-human antigen CD 20), disulfide wit human-mouse monoclonal IDEC-C2B8 kapa-chain, dimer (WHO)

Foreign Names

• Rituximabum (Latin)
• Rituximab (German)
• Rituximab (French)
• Rituximab (Spanish)

Generic Names

• Rituximab (OS: BAN, DCF, USAN)
• Rituximab (Genetical Recombination) (OS: JAN)
• IDEC 102 (IDEC) (IS)
• IDEC C2B8 (IDEC) (IS)

Brand Names

• Acellbia
  Biocad, Georgia
• Blitzima
  Celltrion, Estonia; Celltrion, Slovenia; Celltrion Healthcare, Sweden; Celltrion Healthcare Hungary, Poland
• Mab Thera
  Roche Registration, Slovenia
• MabThera
  F. Hoffmann-La Roche, Macedonia; F. Hoffmann-La Roche LTD, Serbia; Hoffmann-La Roche Ltd, Latvia; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Brazil; Roche, Colombia; Roche, Cyprus; Roche, Czech Republic; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Ireland; Roche, Italy; Roche, Lebanon; Roche, Lithuania; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Peru; Roche, Philippines; Roche, Poland; Roche, Paraguay; Roche, Russian Federation; Roche, Sweden; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Taiwan; Roche, Venezuela; Roche, Vietnam; Roche, South Africa; Roche D.O.O., Serbia; Roche Pharmaceutical, China; Roche Products, United Kingdom; Roche Registration, Romania; Roche Registration Limited, Iceland; Roche Uruguay, Uruguay
• Mabthera
  Roche, Germany; Roche, Pakistan; Roche Products, Australia; Roche Registration, Netherlands
• MabThera 100mg
  Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
• MabThera 10mg/ml
  Roche, Israel
• MabThera 1400mg
  Haemato Pharm, Austria; Orifarm, Austria; Roche, Israel; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
• Mabthera 1400mg/11.7ml
  Roche, Luxembourg
• Mabthera 1600mg/13.4ml
  Roche, Luxembourg
• MabThera 500mg
  Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
• MabThera SC
  Roche, Brazil; Roche Products, Australia
• Novex
  Elea, Argentina
• Reditux
  Complex Therapeutics, Chile; Dr Reddy's Lab, Myanmar; Dr. Reddy's Laboratories, Vietnam
• Rilast
  Hetero, Georgia
• Ritemvia
  Celltrion, Estonia; Celltrion Healthcare, Latvia; Celltrion Healthcare, Netherlands; Orion Pharma, Denmark; Orion Pharma, Finland; Orion Pharma, Sweden
• Ritemvia 500mg
  Celltrion Healthcare, Austria
• Rituxan
  Genentech, United States; Hoffmann-La Roche, Canada; Zenyaku Kogyo, Japan
• Rituxan Hycela [+ Hyaluronidase]
  Genentech, United States
• Rituximab
  Baxter, New Zealand
• Rituzena
  Celltrion Healthcare, Latvia; Celltrion Healthcare, Netherlands; Celltrion Healthcare, Sweden
• Rixanthon
  Sandoz, Latvia
• Rixathon
  Sandoz, Estonia; Sandoz, United Kingdom; Sandoz, Netherlands; Sandoz, Norway; Sandoz, Sweden; Sandoz, Slovenia; Sandoz GmbH, Greece
• Rixathon 100mg
  Hexal, Germany
• Rixathon 100mg/10ml
  Sandoz, Switzerland
• Rixathon 500mg
  Hexal, Germany
• Rixathon 500mg/50ml
  Sandoz, Switzerland
• Riximyo
  Sandoz, Estonia; Sandoz, Latvia; Sandoz, Netherlands; Sandoz, Sweden; Sandoz, Slovenia; Sandoz GmbH, Greece
• Truxima
  Biogaran, France; Celltrion, Georgia; Celltrion Healthcare, Lithuania; Celltrion Healthcare, Romania; Celltrion Healthcare Hungary Kft., Greece; Egis, Georgia; Kern Pharma, Spain; Mundipharma, Belgium; Mundipharma, Germany; Mundipharma Pharmaceuticals, Netherlands; Napp Pharmaceuticals, United Kingdom; Orion Pharma, Sweden
• Truxima 100mg
  Mundipharma, Luxembourg
• Truxima 100mg/10ml
  iQone, Switzerland
• Truxima 500mg
  Mundipharma, Luxembourg
• Truxima 500mg/50ml
  iQone, Switzerland
• Tuxella
  Celltrion, Estonia
• Zytux
  AryoGen, Georgia

Glossary

Further information on drug naming conventions: International Nonproprietary Names.